pyrroles has been researched along with Bleeding in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshikawa, Y; Hoshino, S; Ishikawa, Y; Iwakiri, K; Kaise, M; Kawami, N; Koeda, M; Momma, E; Takenouchi, N; Tanabe, T | 1 |
| Abe, H; Asano, N; Fujimori, K; Fushimi, K; Hatta, W; Imatani, A; Jin, X; Kanno, T; Koike, T; Masamune, A; Nakagawa, K; Nakamura, T; Nakaya, N; Ogata, Y; Saito, M; Tarasawa, K; Uno, K | 1 |
| Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N | 1 |
| Chen, Y; Hong, S; Luo, S; Tan, M; Wang, S; Zhang, L | 1 |
| Aydınok, Y; Balkan, C; Karadaş, N; Kavaklı, K; Önder Siviş, Z; Yılmaz Karapınar, D | 1 |
| Clausse, M; Coulier, B; De Wulf, S; Frognier, R; Rezazadeh Azar, A; Van Cutsem, O | 1 |
| Aarts, MJ; Griffioen, AW; Heemskerk, JW; Kuijpers, MJ; Mattheij, N; Oude Egbrink, MG; Pineda, S; Sabrkhany, S; Sanders, L; van Geffen, JP | 1 |
| Loong, HH; Yeo, W | 1 |
| Hart, RG | 1 |
| Maitland, ML; Snider, KL | 1 |
| Chen, HX; Cleck, JN | 1 |
| Choueiri, TK; Je, Y; Schutz, FA | 1 |
| Minor, DR | 1 |
| Ghenev, P; Izumi, K; Kitagawa, S; Mouri, H; Ohtsubo, K; Takeuchi, S; Yamada, T; Yamashita, K; Yano, S; Yasumoto, K | 1 |
| Alitalo, K; Gjini, E; Hekking, LH; Küchler, A; Post, JA; Saharinen, P; Schulte-Merker, S; Wienholds, E | 1 |
| Fagan, SC; Guan, W; Kozak, A | 1 |
| Berger, PB; Brennan, D; Kereiakes, DJ; Saw, J; Serebruany, VL; Steinhubl, SR; Topol, EJ | 1 |
| Armand, JP; Escudier, B; Faivre, S; Raymond, E; Robert, C | 1 |
| Kamba, T; McDonald, DM | 1 |
| Bhatt, DL; Brennan, DM; Fox, K; Mak, KH; Saw, J; Steinhubl, SR; Topol, EJ | 1 |
| Faerber, GJ; Martinez-Suarez, HJ; Wang, R | 1 |
7 review(s) available for pyrroles and Bleeding
| Article | Year |
|---|---|
Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Hemorrhage; Humans; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Odds Ratio; Phenylurea Compounds; Piperidines; Pyrimidines; Pyrroles; Quinazolines; Ramucirumab; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Sunitinib; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.
Topics: Acidosis; Acute Kidney Injury; Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cytarabine; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hemorrhage; Humans; Hypertension; Indoles; Leukemia, Myeloid, Acute; Male; Neoplasm Proteins; Niacinamide; Pain; Pancytopenia; Phenylurea Compounds; Protease Inhibitors; Pyrroles; Salvage Therapy; Sepsis; Sorafenib; Sunitinib | 2015 |
What's new in stroke? The top 10 studies of 2006-2008. Part II.
Topics: Anticoagulants; Atorvastatin; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Stroke | 2008 |
Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Drug Administration Routes; Female; Hemorrhage; Humans; Hypertension; Indoles; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Signal Transduction; Sorafenib; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |
Adverse effects of anticancer agents that target the VEGF pathway.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Brain Diseases; Capillary Leak Syndrome; Cardiovascular Diseases; Clinical Trials as Topic; Drug Delivery Systems; Drug Interactions; Forecasting; Gastrointestinal Diseases; Hemorrhage; Humans; Indoles; Kidney Diseases; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Risk Factors; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A; Wound Healing | 2009 |
Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.
Topics: Antineoplastic Agents; Benzenesulfonates; Clinical Trials as Topic; Hemorrhage; Humans; Incidence; Indoles; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Risk Assessment; Sorafenib; Sunitinib | 2009 |
Mechanisms of adverse effects of anti-VEGF therapy for cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Hemorrhage; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Signal Transduction; Sorafenib; Sunitinib; Thrombosis; Vascular Endothelial Growth Factor A; Wound Healing | 2007 |
2 trial(s) available for pyrroles and Bleeding
| Article | Year |
|---|---|
Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Topics: Angioplasty, Balloon, Coronary; Atorvastatin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Female; Hemorrhage; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome | 2003 |
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Topics: Atorvastatin; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Pravastatin; Prospective Studies; Pyrroles; Ticlopidine | 2007 |
12 other study(ies) available for pyrroles and Bleeding
| Article | Year |
|---|---|
Risk of hemorrhage and stricture significantly increases in elderly patients with proton pump inhibitor (PPI)-resistant reflux esophagitis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Constriction, Pathologic; Drug Resistance; Esophagitis, Peptic; Female; Fibrinolytic Agents; Hemorrhage; Hernia, Hiatal; Humans; Kyphosis; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2020 |
Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment.
Topics: Aged; Cohort Studies; Female; Hemorrhage; Humans; Japan; Male; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract | 2021 |
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides | 2017 |
CT halo sign and crazy paving pattern due to lung metastases hemorrhage after sunitinib therapy.
Topics: Angiogenesis Inhibitors; Hemorrhage; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2017 |
Sunitinib uptake inhibits platelet function in cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Carcinoma, Renal Cell; Case-Control Studies; Female; Healthy Volunteers; Hemorrhage; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Pyrroles; Signal Transduction; Sunitinib | 2016 |
Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Hemorrhage; Humans; Imatinib Mesylate; Indoles; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Pyrimidines; Pyrroles; Sunitinib | 2008 |
Risk of bleeding not increased by sorafenib or sunitinib.
Topics: Antineoplastic Agents; Benzenesulfonates; Hemorrhage; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib | 2010 |
Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinib.
Topics: Aged; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Carcinoma, Renal Cell; Hemorrhage; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Pulmonary Alveoli; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2010 |
Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity.
Topics: Animals; Antigens, CD; Atorvastatin; Base Sequence; Blood Vessels; Cadherins; Codon, Terminator; Embryo, Nonmammalian; Endocardium; Gene Knockdown Techniques; Head; Heart; Hemorrhage; Heptanoic Acids; Lymphatic Vessels; Molecular Sequence Data; Mutation; Myocardium; Organogenesis; Protein Structure, Tertiary; Pyrroles; Receptor, TIE-1; Receptor, TIE-2; Zebrafish; Zebrafish Proteins | 2011 |
Drug repurposing for vascular protection after acute ischemic stroke.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Brain Infarction; Diabetes Mellitus, Type 2; Disease Models, Animal; Enalapril; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Hemoglobins; Hemorrhage; Heptanoic Acids; Male; Matrix Metalloproteinase 9; Pyrroles; Rats; Rats, Inbred SHR; Rats, Wistar; Reperfusion; Stroke; Tetrazoles; Vascular System Injuries | 2011 |
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?
Topics: Antineoplastic Agents; Benzenesulfonates; Hemorrhage; Humans; Indoles; Nail Diseases; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib | 2005 |
Atorvastatin-induced hemorrhagic cystitis: a case report.
Topics: Aged; Atorvastatin; Cystitis; Female; Hemorrhage; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles | 2009 |